MiNK Therapeutics, Inc.
INKT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,577 | $3,367 | $19,636 | $38,889 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $23 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $411 | $231 | $769 | $723 |
| Total Curr. Assets | $4,988 | $3,598 | $20,405 | $39,635 |
| Property Plant & Equip (Net) | $733 | $954 | $1,067 | $607 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $733 | $954 | $1,067 | $607 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,721 | $4,552 | $21,472 | $40,242 |
| Liabilities | – | – | – | – |
| Payables | $2,728 | $3,912 | $5,823 | $2,996 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,231 | $7,491 | $6,860 | $13,469 |
| Total Curr. Liab. | $6,960 | $11,403 | $12,683 | $16,465 |
| LT Debt | $4,925 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $13,422 | $11,205 | $9,190 | $0 |
| Total NC Liab. | $18,347 | $11,205 | $9,190 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $25,307 | $22,608 | $21,873 | $16,465 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$144,182 | -$133,397 | -$110,939 | -$82,948 |
| AOCI | -$632 | -$431 | -$292 | -$625 |
| Other Equity | $125,227 | $115,772 | $110,830 | $107,349 |
| Total Equity | -$19,586 | -$18,055 | -$401 | $23,776 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $5,721 | $4,552 | $21,472 | $40,242 |
| Net Debt | $348 | -$3,367 | -$19,636 | -$38,889 |